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Abstract
The robustness of complex biological processes in the face of environmental and genetic perturbations is a key biological
trait. However, while robustness has been extensively studied, little is known regarding the fragility of biological processes.
Here, we have examined the susceptibility of DNA replication and repair processes mediated by the proliferating cell nuclear
antigen (PCNA). Using protein directed evolution, biochemical, and genetic approaches, we have generated and
characterized PCNA mutants with increased affinity for several key partners of the PCNA-partner network. We found that
increases in PCNA-partner interaction affinities led to severe in vivo phenotypic defects. Surprisingly, such defects are much
more severe than those induced by complete abolishment of the respective interactions. Thus, the subtle and tunable
nature of these affinity perturbations produced different phenotypic effects than realized with traditional ‘‘on-off’’ analysis
using gene knockouts. Our findings indicate that biological systems can be robust to one set of perturbations yet fragile to
others.
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Introduction
Robustness, the ability to maintain performance in the face of
environmental and genetic perturbations, is a fundamental trait of
biological processes [1–5]. Accordingly, many design principles
ensuring the robustness of biological processes, such as redundan-
cy, modularity, and feedback mechanisms, have been described
[2,6,7]. However, robustness to one class of perturbations can
render the same system fragile to other classes of perturbation.
The concept of robust yet fragile is a well-known feature in the
field of engineering and is one of the most common properties of
complex systems [1,2]. In the case of complex biological processes,
by contrast, very little is known regarding perturbations that result
in enhanced sensitivity or fragility of a process. Understanding
such perturbations could provide new mechanistic insight into
biological processes mediated by complex hub-partner interactions
and could elucidate relationships between the robustness and
fragility of biological processes.
In eukaryotes, DNA replication and repair processes are
mediated by the proliferating cell nuclear antigen (PCNA) through
the recruitment of various DNA-modifying enzymes to the
replication fork [8], including members of different families of
DNA polymerases, helicases, exonucleases, and ligases [9–11].
PCNA forms a sliding platform to enhance the processivity and
catalytic activity of many DNA-modifying enzymes by tethering
them to the DNA template. Remarkably, many of the PCNA
partners interact with a particular loop on PCNA through a
conserved binding motif, suggesting that these partners bind and
dissociate sequentially in order to perform their particular
function. Switching of partners on the PCNA platform is crucial
during different stages of DNA replication and repair, such as
lagging strand replication, translesion synthesis (TLS), mismatch
repair (MMR), and base excision repair (BER) [8]. In recent years,
post-translational PCNA modifications have been shown to be an
important control mechanism regulating partner switching on
PCNA during DNA repair processes [12,13].
To investigate the importance of PCNA-partner interactions for
DNA replication and repair, previous studies have focused on
abolishing these interactions via mutational approaches [14–16].
However, due to the functional redundancy exhibited by PCNA
partners [17], abolishing such interactions often results in
relatively minor phenotypic defects. Hence, an alternative
approach to study the regulation of PCNA-partner interactions
during DNA replication and repair involving systematically
strengthening specific PCNA-partner interactions is required.
Due to the competitive nature of binding to PCNA, strengthening
PCNA-partner interactions could result in prolonged PCNA-
partner association, thereby hindering the binding of other
partners required for the replication and repair processes. Tighter
PCNA-partner interactions cannot, therefore, be suppressed by
functional redundancy within the pool of network proteins and
can thus reveal the importance of accurate regulation of PCNA-
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the system level, this approach could shed new light on the
robustness or fragility of DNA replication and repair in the face of
such perturbations. In recent years, protein engineering method-
ologies, including directed protein evolution [18,19], have proven
to be highly effective for the generation of proteins with increased
binding affinity for target protein partners [20].
In this study, we have examined the robustness or fragility of
PCNA-mediated DNA replication and repair processes in the face
of perturbations altering PCNA-partner interaction affinities. To
do so we have generated and thoroughly characterized a collection
of novel PCNA mutants exhibiting higher binding affinities for five
different partners taking part in a variety of PCNA-mediated
processes, including Pol32, Rad27, Rad30, Msh6, and Ung1,
participating in lagging strand replication, TLS, MMR, and BER,
respectively (Figure 1). Surprisingly, in vivo analysis of these
mutants revealed strong replication defects, indicating the high
sensitivity of these processes to increases in PCNA-partner
interaction affinities. Moreover, these defects illustrate the
importance of a fine balance between different PCNA-partner
interaction affinities for the progression of DNA replication and
repair. The generation and in vitro and in vivo characterization of
the PCNA mutants were performed using a newly developed
integrated platform that includes directed evolution, biochemical,
and genetic approaches (Figure 2).
Results
The Experimental Approach
To generate PCNA mutants with enhanced affinity for different
partners exhibiting a variety of DNA-modifying activities
(Figure 1), we utilized directed evolution methodologies. Directed
evolution experiments are based on the principles of natural
Darwinian evolution and consist of two major steps: (i) creation of
genetic diversity in the target gene in the form of gene libraries and
(ii) effective selection or screening of those libraries for the desired
activity [19,21]. Accordingly, we first generated a large PCNA
mutant library and displayed this library on the yeast cell surface
Author Summary
Many biological processes are mediated by complex
protein-protein interaction networks. The most highly
connected proteins in such networks, termed hub
proteins, precisely regulate biological processes by the
regulated and sequential binding and releasing of partner
proteins. In the case of DNA replication and repair,
proliferating cell nuclear antigen (PCNA) is a hub protein
that encircles the DNA to dynamically bind and release a
variety of DNA-modifying enzymes. In this work, we
explored the impact of subtle alterations of PCNA-partner
interaction affinities on DNA replication and repair in yeast.
Using directed evolution approaches, we generated a large
library of PCNA mutants and selected for those with
enhanced affinity for five different PCNA partners. In vivo
analysis of such mutants indicated the high sensitivity of
DNA replication and repair processes to minor alterations
in PCNA-partner interaction affinities. Importantly, we
discovered that some of the defects observed in the
strains with increased PCNA-partner protein interaction far
exceed the defects observed when the same partner
protein is deleted altogether. Our analysis suggests that
the cost of misregulating biological processes through
disruption of the carefully orchestrated action of hub-
interacting proteins can be much higher than the cost of
deleting parts of the network altogether, demonstrating
both the fragility and robustness of biological processes.
Figure 1. PCNA-partner interaction network mediating DNA replication and repair and PCNA structure. (A) PCNA-partner interaction
network containing the 12 PCNA partners containing PCNA-interacting protein (PIP) used in this study, including DNA polymerases (Pol32 and Rad30,
red), an endonuclease (Rad27, green), partners involved in DNA repair (Msh3, Msh6, Apn2 and Ung1, blue), a helicase (Rrm3, purple), a ligase (Cdc9,
orange), and partners involved in various processes, including loading PCNA onto DNA (Rfc1, brown), sister chromatid cohesion (Eco1, brown), and
chromatin acetylation (Cac1, brown). PCNA was evolved for higher binding affinity for Pol32, Rad30, Rad27, Msh6, and Ung1 (highlighted in bold). (B)
Model of the PCNA structure (PDB code:1PLQ) [25]. Each monomer is shown in white, grey, or black. The IDCL loop is highlighted in red and the K164
residue is highlighted in blue. The model was generated using the UCSF chimera program.
doi:10.1371/journal.pbio.1000507.g001
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with enhanced affinity for the target partner, the displayed PCNA
library was incubated with biotinylated peptide derived from the
target partner (see below) and streptavidin-conjugated allophyco-
cyanin (APC), in addition to a fluorescent antibody against the
myc-tagged PCNA. The top fluorescent cell population was
selected by fluorescence-activated cell sorting (FACS; Figure 2A,
Step 2 and Figure 2B). Next, the enriched libraries were sub-
Figure 2. Work-flow for the generation and characterization of PCNA mutants with enhanced affinity for different partners. (A)
Overview of the workflow, including generation and sorting of PCNA libraries displayed on the yeast cell surface (Step 1 and 2) and subsequently
subjecting the enriched libraries to ELISA to identify improved mutants (Step 3). Binding characterization of the selected PCNA mutants by the yeast
two hybrid system (Y2H) and surface plasmon resonance (SPR) is next performed (Step 4). Finally, in vivo characterization of the PCNA mutants in
yeast cells is conducted (Step 5). (B) Detailed description of the selection process of the PCNA library displayed on the yeast cell surface for PCNA
mutants with improved affinity for PIP peptides derived from the different partners, relying on yeast surface display (YSD) and flow cytometry (Step
2). (C) Detailed description of the ELISA assay used for the detection of PCNA-PIP peptide interactions (Step 3). Target biotinylated PIP peptides
derived from the different partners (see Figure S1 for sequences) are immobilized on streptavidin-coated plates. E. coli cell lysates containing
66histidine-tagged mutant PCNA are applied to the plates. Following washing, primary and secondary antibodies are added to facilitate the
detection of PCNA binding to the PIP peptides.
doi:10.1371/journal.pbio.1000507.g002
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enhanced affinity for the target partners, using an enzyme-linked
immunosorbent assay (ELISA). The ELISA experiment for the
detection of PCNA-PIP peptide interactions was performed with
crude E. coli cell lysates containing the different mutants incubated
with biotinylated PIP peptide-coated plates. The amount of bound
PCNA was analyzed using antibodies against the 66histidine-
tagged PCNA (Figure 2A, Step 3 and Figure 2C). To further
characterize the binding profile of selected PCNA mutants toward
an array of partners, yeast two hybrid (Y2H) [23] and surface
plasmon resonance (SPR) [24] assays were used (Figure 2A, Step
4). Finally, to examine the in vivo activities of the selected PCNA
mutants, these were reintroduced as a sole source of PCNA into
yeast cells using plasmid shuffle of centromeric plasmids in a strain
lacking the chromosomal POL30 gene. The resulting strains were
subjected to a variety of DNA replication and repair assays
(Figure 2A, Step 5).
Generation and Enrichment of the PCNA Library Using
Yeast Surface Display (YSD)
PCNA interacts with most of its partners through an inter-
domain connecting loop (IDCL) that connects the two domains of
the PCNA monomer (Figure 1B) [25]. Other sites of interactions
include residues at the C-terminal and N-terminal regions of
PCNA [26–29]. Accordingly, the majority of PCNA partners
contain a conserved binding motif termed the PIP (PCNA-
interacting protein) box, located in the N- or C-terminal region of
the partner, distinct from its active site (see Figure S1 for peptide
sequences) [9,10]. To generate a large PCNA mutant library, we
focused on the diversification of the IDCL region while
maintaining the conserved IDCL residues constant due to their
specific interactions (e.g. residues I126 and L128) with conserved
residues in the PIP region [29,30]. We hypothesized that the non-
conserved residues may control the specificity of the different
PCNA-partner interactions. Therefore, we fully diversified the
I121, A123, F125, and E129 non-conserved positions (Figure S2),
yielding a library including 160,000 different mutants.
To establish a high-throughput screening system for the
detection of PCNA binding to PIP peptides derived from the
different partners (Figure 1), we efficiently displayed PCNA
capable of binding the target PIP peptides on the outer membrane
of yeast cells using YSD methodology (Figure S3A) [22]. To
confirm that the observed PIP peptide binding was a result of
specific PCNA-PIP interactions, we tested the binding of WT
PCNA to a mutated Rad30 PIP peptide [15], as well as the
binding of an inactive PCNA mutant (i.e., PCNA79) [31] to the
Rad30 PIP peptide (Figure S3B–D). In both experiments, a
dramatic reduction in binding affinity was observed, indicating a
specific interaction between the IDCL and the PIP peptide (Figure
S3B–D).
To enrich the PCNA library for PCNA mutants with enhanced
affinity for the target partners (Figure 1A), yeast cells expressing
the PCNA library were independently incubated with the five PIP
peptides and more than 5610
6 cells were analyzed and sorted by
FACS (Figure 2B). Three to five iterative rounds of enrichment
were performed until a significant enrichment for PCNA mutants
with increased affinity for all PIP peptides was obtained (Figure 3).
Identification and Characterization of PCNA Mutants
To identify single PCNA mutants with enhanced binding
affinity for target partners, the five FACS-enriched libraries
(Figure 3) were sub-cloned into a bacterial plasmid, overexpressed
in E. coli, and screened by ELISA (Figure 2C). Using this
approach, the crude cell lysates of 10–20 clones from each of the
five enriched libraries were screened for binding to a given PIP
peptide. The top performing 2–4 mutants from each of the five
ELISA screens (Table 1) were then taken for further in vitro and in
vivo characterization, as described below.
To verify that the selected PCNA mutants showing increased
affinity for the PIP peptides also exhibit increased affinity for the
full-length partner, a Y2H analysis was performed. For the Y2H
assay, we used the YRG2 host strain, shown to be highly efficient
in coupling the strength of protein-protein interactions with
growth on media lacking histidine [32]. Selected PCNA mutants
were characterized for their ability to bind each of 12 main PCNA
partners [8] to obtain specificity profiles (Table 1, Table S1, and
Figures S4–S5). Such profiling indicated, in most cases, that an
increase in binding affinity for the target partner did not result in
increased or decreased affinity for the other partners (Table 1,
Table S1). These results demonstrate the high flexibility of the
IDCL in terms of increased binding specificity. However, in some
cases a strong trade-off between the bindings of different partners
was observed. For example, some PCNA mutants selected for high
affinity to Rad27 exhibited reduced affinity for Rad30 and vice
versa (Table 1).
To examine whether increased PCNA-partner interaction
affinities result in increased PCNA-partner complex formation in
vivo in pol30 mutant strains, we analyzed the levels of these
complexes extracted from yeast cells. We used strains expressing
the pol30 mutants as a sole source of PCNA in the cell under the
control of the native POL30 promoter (see below). We immobilized
PCNA from the crude yeast extracts onto ELISA plates and
analyzed the amount of bound partner, relative to the amount of
total PCNA immobilized on the plate (Figure 4). Using this
approach, we successfully identified an increase of 70% and 17%
in the amount of PCNA-Rad30 and PCNA-Rad27 complexes
extracted from pol30 mutant strains with increased affinity for
Rad30 and Rad27, respectively, relative to the POL30 strain
(Figure 4). However, we did not detect an increase in PCNA-Msh6
or PCNA-Ung1 complex formation, probably due to the relatively
minor increase in affinities of these interactions (1.6- and 3.5-fold,
respectively, see Table 1) and the transient nature of PCNA-
partner interactions [33].
To quantify differences in binding affinities of the PCNA
mutants relative to the WT, we characterized four PCNA mutants
with increased affinity for PIP peptides derived from Rad30,
Pol32, Msh6, and Ung1 partners using SPR. These mutants were
overexpressed in E. coli, purified by affinity chromatography, and
immobilized on an SPR sensor chip for binding characterization
[14]. SPR binding analysis enabled direct and sensitive measure-
ment of interaction affinities relative to the Y2H system and
indicated an up to 8-fold increase in binding affinity for the
different PIP peptides, relative to WT PCNA (Table 1). Such
analysis allowed the detection of a significant decrease in the
Rad30 PIP peptide dissociation rate in the Pol30-Rad30E9p
mutant relative to the WT, indicating a ,9-fold increase in the
lifetime of the PCNA-Rad30 complex (see Table 1). Collectively
the ELISA, Y2H, and SPR assays validated and quantified the
increase in mutant PCNA binding affinities, relative to WT
PCNA.
To validate that the PCNA mutations have not altered the
ability of that mutant to form an intact PCNA structure, we
characterized six different PCNA mutants showing increased
affinity for different partners. We used gel filtration chromatog-
raphy analysis of the purified PCNA mutants to examine the
molecular mass of the proteins under non-denaturating conditions.
Using this approach, we found that all mutants form intact trimers
of molecular mass of ,90 kDa, similar to WT PCNA (Figure S6).
The Fragility of PCNA Mediated DNA Replication
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previously shown to be defective in trimer formation [34], and
detected a molecular mass of a monomer of ,30 kDa (Figure S6).
In addition, we examined the secondary structure content of the
PCNA mutants, in comparison to the WT, using Circular
Dichroism (CD) spectroscopy. This experimental approach allows
examining whether the mutations in PCNA led to substantial
structural alterations. We found that the CD spectra of the
mutants are very similar to the CD spectrum of the WT PCNA
(see Figure S6). Overall, these results indicate that the PCNA
mutations did not significantly alter the secondary structure of
PCNA or its ability to form trimers.
Sequence analysis of the selected mutants revealed the presence
of 3–4 mutations in the IDCL region out of the 4 positions
randomized in the naı ¨ve library (Table 1). Surprisingly, some of the
PCNA mutants identified following Rad27 PIP selection were
characterized by a deletion of two amino acids after the first aspartic
acid of the IDCL region (Figure 1B, Table 1) [25]. This deletion
results in altered pattern of PCNA-partner specificity (Table 1) due
to shortening of the exposed and flexible IDCL loop that may result
in new conformational diversity. To validate the effect of the
deletion, we generated the same deletion on the background of WT
PCNA and observed similar binding specificity, relative to the
selected deletion mutants (unpublished data).
In Vivo Characterization of PCNA Mutants
To study the in vivo ability of PCNA mutants to promote
DNA replication and repair in yeast, we adopted a plasmid
shuffling method to create haploid yeast strains carrying each
mutant as the sole source of PCNA (see Materials and Methods).
This approach allowed us to identify PCNA mutants leading
to cell death, indicating their inability to support essential DNA
replication processes (Figure 5A). In addition, many of the mutant
strains exhibited high sensitivity to DNA damaging agents, such
as hydroxyurea (HU) or methyl methanesulfonate (MMS),
drugs that cause global replication stress and DNA alkylation,
respectively (Figure 5B). Interestingly, the lethality or strong
sensitivity displayed by our mutants presenting increased affinity
for various partners far exceeds the sensitivity observed for the
previously studied pol30-79 mutant, exhibiting a significant
decrease in binding affinity for the majority of PCNA partners
(Figure 5B) [31]. To verify that the replication defects in the
mutant strains (Figure 5) are not due to reduced expression
levels of the PCNA proteins, we confirmed the expression level
of PCNA using western blot analysis and observed similar
expression levels of all PCNA mutants, relative to WT PCNA
(Figure S7).
Next, we examined the sensitivity of strains containing single
deletions of each of the five different partners on a WT PCNA
Figure 3. Enrichment of PCNA libraries displayed on the yeast cell surface for mutants exhibiting increased affinity for the target
PCNA partners, as assessed by flow cytometry. FACS histogram analysis of cells displaying wild-type PCNA (red), a naı ¨ve library (green), and
libraries following 3–5 rounds of enrichment (blue), following incubation with biotinylated PIP peptide derived from Rad30 (A), Rad27 (B), Pol32 (C),
Msh6 (D), or Ung1 (E). Binding of PIP peptides was measured following subsequent incubation with allophycocyanin (APC)-labeled streptavidin
(x-axis).
doi:10.1371/journal.pbio.1000507.g003
The Fragility of PCNA Mediated DNA Replication
PLoS Biology | www.plosbiology.org 5 October 2010 | Volume 8 | Issue 10 | e1000507background. We found that these strains exhibit equal or lesser
phenotypic defects, relative to the selected PCNA mutant strains
with increased affinity for the respective partner (Figure 5B). These
results suggest that the cost for increasing PCNA-partner
interaction affinity is equal to or much higher than the cost of
that partner being absent (Figure 5B, see Rad30 and Ung1 as
prominent examples). To further test this idea and validate that
the mutations in PCNA do not disrupt any critical PCNA function
unrelated to PCNA-partner interactions, we examined whether
deletion of different partners on the background of the pol30
mutant strains can suppress the growth sensitivity phenotypes. We
first examined whether the rad27 deletion can suppress the lethality
of a strain containing the pol30-Rad27L1 or pol30-Rad27L2
mutants (Figure 6A). It was previously shown that rad27 deletion
does not cause lethality [35]. Interestingly, rad27 deletion
suppressed the lethality of the pol30-Rad27L1 and pol30-Rad27L2
strains probably due to the lack of PCNA-Rad27 complexes in
these strains (Table 1, Figure 6A). This result demonstrates that
the strong deleterious effect of PCNA mutants with increased
binding affinity for Rad27 could be much higher than the effects of
rad27 deletion and firmly correlates with our in vitro and in vivo
analyses of the PCNA mutants. We also found that the rad27
deletion can suppress the phenotypes of other pol30 mutant strains
(Figure S8), however such suppression could be due to indirect
pathway activation [36]. In addition, we examined whether rad30
deletion, ung1 deletion, and msh6 deletion can suppress the
phenotypes of the pol30 mutants with increased affinity to
Rad30, Ung1, and Msh6, respectively (Figure 6B–D). We found
that indeed such deletions suppressed the growth sensitivity
phenotypes of the pol30 mutants with increased affinity for
Rad30 or Ung1 and the high spontaneous mutation rate observed
in the pol30 mutant with increased affinity to Msh6 (Figure 6B–D).
However, since the suppression of the strain phenotypes was not
complete, additional factors, such as minor effects of the mutations
on other PCNA-partner interactions, may play a partial role in the
sensitivity phenotype of the examined pol30 mutants. Collectively
the suppression of the phenotypes of the pol30 mutant strains by
PCNA partner-deletions suggests that these phenotypes arise
mainly as a result of specific enhancement of PCNA-partner
interactions and that the pol30 mutants are not defective in any
critical function unrelated to PCNA-partner interactions. We also
examined whether overexpression of different partners can
suppress the growth sensitivity of the pol30 mutants, however no
suppression was observed (Figure S9).
It was previously shown that PCNA contains another site of
regulation (i.e. K164) that is modulated by ubiquitination or
SUMOylation (Figure 1B) and that is crucial for the recruitment of
TLS polymerases [13,37]. To test whether the K164 regulatory
site is active in the PCNA mutant strains, we examined the
spontaneous mutation rate in these strains (Table 1). Increase in
spontaneous mutation rate can indicate the recruitment of TLS
polymerases to PCNA through K164 ubiquitination [13,37].
Table 1. Summary of the in vitro and in vivo characterization of PCNA mutants.
PCNA (POL30) Mutant IDCL Sequence
a Binding of PCNA Mutants to Target Partners
b
Spontaneous Mutation Rate
e
Can
R (Fold Increase)
Rad30 Rad27 Pol32 Msh6 Ung1
POL30 DI IDA ADF FLKIE EEL 1 1 1 1 1 1.5 [1.5, 2.2]610
27
pol30-Rad30E2 DD DDW WDFLKIL LEL 1.4
c 0.4
c 0.4
c 1 1 1.5 [1.5, 2.0]610
26 (10)
pol30-Rad30E9 DN NDW WDFLKID DEL 1.6
c (8.5)
d 0.5
c 1 1 1 2.3 [1.7, 3.0]610
26 (15.3)
pol30-Rad27E6 DG GDY YDI ILKIR REL 1 1.5
c 1 1 1 1.2 [0.8, 1.4]610
26 (8)
pol30-Rad27E31 DG GDY YDV VLKIR REL 1 1.5
c 11 1 N D
pol30-Rad27L1
f D––V VDI ILKIG GEL 0.4 1.7
c 11 1 N A
pol30-Rad27L2
f D––V VDT TLKIT TEL 0.5 1.5
c 11 1 N A
pol30-Pol32E5 DA ADN NDFLKIS SEL 11 1.5
c 1 1 2.0 [1.4, 2.8]610
26 (13.3)
pol30-Pol32E9 DN NDV VDS SLKII IEL 1 1.2 1.3
c (2)
d 1 1 6.0 [4.7, 7.1]610
27 (4)
pol30-Msh6E2 DY YDR RDM MLKIS SEL 1 1.3 1 1.4
c 1 1.1 [0.7, 1.6]610
26 (7.3)
pol30-Msh6E6 DY YDK KDL LLKII IEL 1 1.3 1 1.4
c (1.6)
d 1 6.1 [5.1, 8.8]610
27 (4.1)
pol30-Ung1E2 DD DDS SDFLKIP PEL 11 1 11.3
c 3.3 [2.2, 3.3]610
27 (2.2)
pol30-Ung1E3 DF FDY YDE ELKIEEL 11 1 11.3
c (3.5)
d 3.1 [2.1, 3.9]610
27 (2.1)
pol30-79 DIDADFA AKA AEEL 0.4
c 0.5
c 0.3
c 0.4
c 0.3
c 3.3 [2.2, 5.1]610
27 (2.2)
aThe IDCL sequences of the PCNA mutants. The positions that were diversified in the naı ¨ve library and mutations identified in the selected mutants are marked in bold.
The mutations in pol30-79 [31] are marked in bold.
bBinding characterization of the PCNA mutants for the five target partners (see Figure 2) using Y2H and SPR assays. Growth of the Y2H strain containing WT and mutant
PCNA and the different partners was analyzed on selective agar plates lacking histidine. Growth rates similar to that of cells expressing WT PCNA are denoted as 1.
Increase and decrease in affinity detected by Y2H or SPR assays are marked in bold.
cFold increase or decrease in the PCNA-partner interaction affinities measured as the generation time of the Y2H strains grown in liquid selective media lacking histidine,
relative to cells expressing WT PCNA (see Figures S4 and Materials and Methods).
dFold increase in binding affinities of PCNA mutants for PIP peptides derived from the different partners (in parenthesis), relative to WT PCNA, as measured by SPR
analysis. Binding affinities of the WT PCNA for Rad30, Pol32, Msh6, and Ung1 PIP peptides are 1.7610
27M, 3.6610
27M, 3610
26M, and 1.2610
26M, respectively. The off-
rate (kd) of the Rad30 PIP peptide measured for the WT and pol30-Rad30E9 mutant are 0.03 s
21 and 0.00321 s
21, respectively.
eThe spontaneous mutation rate was determined by fluctuation analysis (see Materials and Methods). Values in brackets represent the low and high limits for the 95%
confidence interval obtained for each rate. The numbers in parentheses indicate the fold increase, as compared to the WT POL30 strain. The differences between the
mutation rate of the mutants and the WT are significant (p,0.002 in all cases, Mann-Whitney test).
fStrains containing these mutants as the sole source of PCNA are non-viable.
ND, not determined; NA, not applicable.
doi:10.1371/journal.pbio.1000507.t001
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mutation rate by reducing DNA replication processivity and
causing replication fork stalling, thereby leading to TLS
recruitment [37]. These mutants can also indirectly alter Pol-d
or Pol-e proofreading leading to TLS recruitment [37]. We
measured the spontaneous mutation rate using the CAN1 reporter
assay by monitoring the ability of the PCNA mutant strains to
grow in the presence of canavanine, a toxic analogue of arginine
[38]. Interestingly, we observed a significant increase in the
mutation rate in most of the PCNA mutant strains, relative to WT
PCNA (Table 1). To examine whether Polf, the major TLS
polymerase [13,37], is recruited in vivo to PCNA mutants showing
increased affinity for Rad27 and Pol32 (pol30-Rad27E6 and pol30-
Pol32E5, Table 1) upon K164 ubiquitination, we measured the
spontaneous mutation rates of these mutant strains on the
background of either mutated rev3 encoding the catalytic subunit
of Polf or mutated rad18 encoding the K164 ubiquitin ligase or
K164R mutation (Figure 7, Table 2). We observed a dramatic
reduction in the mutation rates of all of these strains, indicating
that the high mutation rate in the pol30 mutant strains is a result of
Polf recruitment to the PCNA mutants through K164 ubiquitina-
tion (Figure 7, Table 2). Collectively, these results indicate the
functional separation between IDCL and K164 ubiquitination in
regulating partner binding to PCNA.
Finally, to examine the mutation spectra at the CAN1 locus for
pol30 mutant strains with increased affinity to Pol32 or Rad27, we
sequenced the CAN1 gene in individual canavanine resistance
clones. We sequenced 37 and 26 CAN1-inactivating mutations
isolated from the pol30-Pol32E5 and pol30-Rad27E6 mutants,
respectively. We found that pol30-Pol32E5 mutant accumulated a
broad range of mutations, including substitutions, frame-shifts, or
deletions (Table S2). Interestingly, we observed that 20% of the
Figure 4. Increased levels of in vivo PCNA-partner complex formation in the pol30-Rad30E2 or the pol30-Rad27E6 mutant strains,
relative to the POL30 strain. (A). ELISA experimental set-up for the detection of PCNA-partner complexes extracted directly from WT and mutant
PCNA strains. The assay is based on the immobilization of PCNA-partner complex using anti-PCNA antibody-coated ELISA plates. Detection of
complex levels is performed using antibodies against the GFP fused to the C-terminal of the PCNA partner. The level of extracted complex is
normalized to the total levels of PCNA immobilized on the plate using antibodies against a 66histidine tag fused to PCNA. (B,C) The ELISA signal of
the PCNA-Rad30 (B) or PCNA-Rad27 (C) complex normalized to the overall immobilized PCNA signal. The increase in complex formation in the pol30-
Rad30E2 (B) and pol30-Rad27E6 (C) mutant strains, relative to the POL30 WT strain, is 70% and 17% for the PCNA-Rad30 and PCNA-Rad27 complexes,
respectively.
doi:10.1371/journal.pbio.1000507.g004
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nucleotides flanked by a 4 bp direct repeat (Table S2). This result
suggests that polymerase slippage is one of the mutagenic
mechanisms leading to the increased mutation rate of the pol30-
Pol32E5 mutant strain [39]. In contrast, the pol30-Rad27E6
accumulated a very low frequency of deletions (4%) but a high rate
of substitutions and frame-shifts (Table S2). We also analyzed the
CAN1-inactivation mutations accumulated in the pol30-Pol32E5
and pol30-Rad27E6 mutants generated on the background of rev3-
deletion or pol30-K164R mutation. We found that these mutants
accumulated low levels of substitution with no deletions or frame-
shifts (Table S2), suggesting that the diverse mutation spectra in
the characterized pol30 mutant strains is dependent upon REV3
and K164 modification.
Figure 5. In vivo phenotypic analysis of PCNA mutants. (A) Non-viable strains containing PCNA mutants with increased binding affinity for
Rad27 as the sole version of PCNA. Yeast strains containing WT PCNA expressed from a URA3 plasmid and mutant PCNA genes expressed from a LEU2
plasmid are viable (middle). Upon selection for loss of WT PCNA using 5-floororotic acid (5FOA), PCNA mutant strains are non-viable (right). (B) MMS
(middle) and HU (right) sensitivity of strains containing PCNA mutants with increased binding affinity for Rad27, Pol32, Rad30, Msh6, and Ung1 and
strains containing WT PCNA in which the same partners were deleted. For binding characterization and sequences of the mutants, see Table 1.
doi:10.1371/journal.pbio.1000507.g005
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In this study, we have generated and examined a novel collection
of PCNA mutants with increased binding affinity for several
partners, relative to WT PCNA. We have established an integrated
approach that allows us (1) to generate PCNA mutants with
increased affinity for different partners, (2) to perform binding
characterization of the mutants for many different partners in order
to profile changes in binding specificity, and (3) to perform detailed
in vivo characterization of the mutants for the detection of defects in
DNAreplicationandrepair.The generation ofPCNA mutantswith
increased affinity for five different partners revealed the high
plasticity of PCNA for increases in partner interaction affinities,
implying that the WT IDCL sequence naturally evolved to bind
multiple partners with moderate affinity, rather than adopting
higher bindingaffinities forspecific partners. This property could be
a selectable evolutionary trait designed to maintain the dynamic
nature of PCNA-partner interactions and to facilitate partner
switching on PCNA. The large number of mutations and the lack of
conservation observed in the selected mutants (Table 1) suggests
that binding affinity for the PIP region involves diverse contribu-
tions from many IDCL residues and that multiple solutions exist for
increases in PCNA-partner binding affinities (Table 1).
In vivo analysis of the different mutants revealed severe
phenotypic defects, ranging from non-viability to high sensitivity
to DNA-damaging agents (Figure 5). In contrast, abolishment of
PCNA-partner interactions by mutating conserved residues in
PCNA [31] or in the PIP region of the different partners [14,16] or
even by deletion of different partners results, in most cases, in
relatively minor phenotypic defects (Figure 5) [14,16]. Collectively,
Figure 6. The suppression of pol30 mutant strain phenotypes by the deletion of PCNA partner-encoding genes. (A) Lethality in yeast
strains containing PCNA mutants with increased affinity for Rad27 can be suppressed by rad27 deletion. General scheme describing the suppression
of lethality (left). The growth analysis of pol30 mutant and WT strains generated on the background of the parent or rad27-deleted strain (right).
Strains containing each PCNA mutant as a sole source of PCNA were generated by transformation with a URA3-marked plasmid containing the POL30
gene and a LEU2-marked plasmid containing pol30-Rad27L1, pol30-Rad27L2, or POL30 (used as a control), followed by plating onto 5-FOA to force the
loss of the URA3 plasmid (see Materials and Methods for detailed description). (B,C) The suppression of pol30-Rad30E2, pol30-Rad30E9 (B), pol30-
Ung1E2, and pol30-Ung1E3 (C) strain growth sensitivity phenotypes by rad30 (B) or ung1 deletion (C). POL30 and the pol30 mutant strains were
generated and examined as described above. (D) Suppression of the level of spontaneous mutation rate of the pol30-Msh6E2 mutant strain by msh6
deletion.
doi:10.1371/journal.pbio.1000507.g006
The Fragility of PCNA Mediated DNA Replication
PLoS Biology | www.plosbiology.org 9 October 2010 | Volume 8 | Issue 10 | e1000507these results highlight the fragility of DNA replication and repair
resulting from increased PCNA-partner interaction affinity, in
contrast to the robustness detected in the face of abolishment of
the same interactions. Functional redundancy in PCNA partners
could be the major mechanism facilitating the robustness of the
PCNA-partner interaction network in coping with an abolishment
of PCNA-partners interactions [5]. Indeed, several publications
have indicated that the exonuclease activity of Pold can substitute
for the 59flap endonuclease activity of Rad27 in processing
Okazaki fragments, thereby preventing genome instability [17,40].
What could be the mechanistic basis for the severe phenotypic
defects observed in the PCNA mutant strains? PCNA mutants
showing increased binding affinities for different partners may
experience prolonged PCNA-partner associations, thus altering
partner switching at the PCNA IDCL region. Indeed, SPR
analysis of the pol30-Rad30E9p mutant (Table 1) indicates that the
increase in the binding affinity of a given partner is due to a
decrease in that partner’s dissociation rate (koff rate, see Table 1).
The phenotypic defects in the pol30 mutant strains (Figure 5) were
detected in strains containing PCNA mutants with relatively minor
increases in affinity for different partners. SPR analysis indicated
an up to 8-fold increase in binding affinity of PCNA for the
different partners, indicating the high impact of such alterations on
DNA replication and repair processes in vivo. Such defects
indicate that affinity-based competition between different partners
is a crucial factor for the regulation of PCNA-partner interactions
during different stages of DNA replication and repair. This,
moreover, suggests that these are highly dynamic processes that
require multiple partner binding and dissociation events [41]. In
support of this hypothesis, different stages of DNA replication and
repair, such as lagging strand replication, TLS, and BER, require
the sequential binding of multiple PIP-containing partners to the
IDCL [8]. However, it is important to note that the mutations in
the IDCL region of the pol30 mutants leading to increased affinity
for various partners can still disrupt other important in vivo
functions of PCNA. For example, such mutations can affect the
PCNA in vivo localization or loading onto the DNA, thus
contributing to the phenotypic defects observed in the pol30
mutant strains. Future work analyzing these in vivo PCNA
properties would contribute to the characterization of the PCNA
mutants described in this study. In addition, future in vitro assays
would allow further analysis of the effects of increasing PCNA-
partner interactions on partner switching on PCNA during the
different steps of DNA replication and repair.
One of the phenotypes of the PCNA mutant strains is a
significant increase in the spontaneous mutation rate at the CAN1
gene, indicating the recruitment of TLS polymerases to PCNA
(Table 1). To obtain deeper mechanistic insight into such
recruitment, we have shown that this phenotype is suppressed by
the deletion of either rev3 [42] or rad18 or by the K164R mutation
(Figure 7) [12]. These results indicate that the increase in PCNA
Figure 7. The increase in the spontaneous mutation rate of
PCNA mutants is dependent upon Polf recruitment and
ubiquitination of PCNA at K164. The effects of the rev3, rad18,
and K164R PCNA mutations on the spontaneous mutator phenotype of
PCNA mutants with increased affinity for Rad27 (A, pol30-Rad27E6) and
Pol32 (B, pol30-Pol32E5) are shown. The data are rates of Can
r mutation
and are medians representing values that are within the 95%
confidence limits for at least 25 independent determinations. The exact
values of the spontaneous mutation rate in the different strains are
presented in Table 2.
doi:10.1371/journal.pbio.1000507.g007
Table 2. Spontaneous mutation rate analysis at the CAN1
locus.
Genotype Mutation Rate
c
Fold Increase
Relative to WT
POL30 1.5610
27 [1.5, 2.2] 1
pol30-Rad27E6 1.2610
26 [8.0, 13.9] 7.7
pol30-Rad27E6/K164R
a 4.1610
27 [2.8, 5.3] 2.7
pol30-Rad27E6/rev3
b 2.6610
27 [2.6, 3.9] 1.7
pol30-Rad27E6/rad18
b 6.6610
27 [4.5, 7.9] 4.4
pol30-Pol32E5 2.0610
26 [13.6, 27.6] 13
pol30-Pol32E5/K164R
a 4.6610
27 [3.2, 7.4] 3.0
pol30-Pol32E5/rev3
b 2.1610
27 [2.1, 2.1] 1.4
pol30-Pol32E5/rad18
b 3.2610
27 [2.9, 4.5] 2.1
aSpontaneous mutation rate analysis of pol30-Rad27E6 or pol30-Pol32E5 mutant
strains also containing the K164R mutation in the POL30 gene.
bSpontaneous mutation rate analysis of pol30-Rad27E6 or pol30-Pol32E5
mutants generated on the background of the rev3-o rrad18-deleted strains.
cThe numbers in brackets represent the low and high values for the 95%
confidence interval for each rate, obtained using the confidence interval for
the median test. The medians and 95% confidence intervals were deduced
from at least 25 independent determinations for each strain.
doi:10.1371/journal.pbio.1000507.t002
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of Polf to the replication fork via K164 ubiquitination.
Furthermore, our data indicate a functional separation between
the IDCL and K164 regulatory sites and suggest that the
recruitment of Polf by K164 modification can provide a back-
up mechanism by which to sustain replication in cases of
regulation defects involving the IDCL region. Examination of
the mutation spectra at the CAN1 locus of CAN1- resistant clones
isolated from the pol30-Pol32E5 and pol30-Rad27E6 mutant
strains indicated the accumulation of a broad range of mutations
and a significant difference in the mutation spectra between these
strains (Table S2). These results indicate that increased PCNA-
partner interactions can lead to different mutations, demonstrating
different characteristics of each mutant (Table S2). In addition, the
pol30-Rad27E6 accumulated mutations were different from the
mutations previously found in the rad27-deleted strain [35]. The
mutations in the rad27-deleted strain were characterized by a high
frequency of duplications, indicating severe impairment of lagging
strand replication [35]. This comparison suggests that pol30-
Rad27E6 affects the regulation of lagging strand replication, rather
than leading to complete abolishment of Rad27 enzymatic activity.
To facilitate the generation and examination of PCNA mutants
with increased affinity for several partners, we have developed an
integrated platform based on directed evolution and yeast genetic
approaches. Currently, the most common manner of employing
genetics for studying the robustness of cellular processes addresses
the all-or-none effects generated by gene knock-outs (5). The
integrated approach that we have developed allows for the
generation of much more subtle and controlled perturbations to
revealnew properties ofthe DNAreplicationsystem.Thisapproach
does not directly affect the expression level of the proteins or the
catalytic activities of the different partners, thus allowing for
dissection of the effects of subtle alterations in PCNA-partner
binding affinities on the replication process. In future studies, the
mutants generated in this study could prove useful in efforts aimed
at obtaining mechanistic insight into PCNA-partner binding and
dissociation events during DNA replication and repair processes.
In summary, using DNA replication and repair as a model
system, we have shown that biological processes can be highly
robust to one set of perturbations yet at the same time be highly
fragile to completely different perturbations. Our data thus
provide a more balanced view on the robustness of biological
processes and reveal that similar to many man-made complex
systems, these processes possess both properties of robustness and
fragility. Finally, the approach developed in this study, which
allows for the generation of a variety of minor perturbations in a
protein-protein interaction network, can be applied to study the
molecular basis, mechanism, and fragility of other networks
promoting different biological processes, including signal trans-
duction and gene transcription.
Material and Methods
Plasmids
For E. coli expression, WT PCNA and the different mutants were
cloned into plasmid pET28 (Novagen) using the NdeI and XhoI
sites to yield a 66Histidine-tagged version of the protein. For YSD,
WT PCNA was cloned into plasmid pCTCON [22] using the NheI
and BamHI sites to generate plasmid pCTCON-PCNA. For in vivo
testing of PCNA mutants, a 200 bp PCNA-promoter region and a
300 bp PCNA-terminator region were amplified from genomic
DNA using the fr-pro and rev-pro and the fr-ter and rev-ter primers
for the promoter and terminator regions, respectively (Table S3).
These fragments were cloned into the pRS315 and pRS316
centromeric plasmids using NotI and SpeI or HindIII and XhoI
sites, respectively, to generate the pRS315-proterm and pRS316-
proterm plasmids. WT and mutant PCNA genes were amplified
using fr-pRS/PCNA and rev-pRS/PCNA primers and cloned into
pRS315-proterm and pRS316-proterm plasmids by homologous
recombination. PCNA partners were GFP-tagged at their natural
locus using a GFP-cassette as previously described [43]. For the
Y2H assay, the pAD-GAL4 and pBD-GAL4 plasmids (Stratagene)
were used to clone WT or PCNA mutants and the various partners,
respectively (see Table 1, Tables S1 and Table S3 for a list of
partners and oligonucleotides, respectively).
YSD of PCNA
PCNA was displayed on the yeast cell surface of EBY100 strain
cells (see [22] for genotype) and analyzed by flow cytometry,
essentially as described [22]. Briefly, EBY100 transformed with
plasmid pCTCON-PCNA were grown in SDCAA media to
logarithmic phase and 2610
6 of cells were washed, resuspended in
SGCAA induction media, and grown at 20uC with shaking for an
additional 18 h. Induced cells (1610
6) were collected by
centrifugation, washed with PBSF (PBS+ 1 g/L BSA), and
incubated for 1 h at 25uC with mouse a-Myc antibodies (Santa
Cruz Biotechnology, 1 ml/50 ml PBSF) and 100–400 mMo f
biotinylated PIP peptide (Peptron, see Figure S1 for peptide
sequences). Subsequently, cells were washed and incubated with
FITC-conjugated a-mouse IgG (Sigma, 1 ml/50 ml PBSF) and
APC-conjugated streptavidin (Jackson Immunoresearch, 1 ml/
50 ml PBSF) for an additional hour on ice, with frequent mixing.
The labeled cells were washed, resuspended with PBSF, and
analyzed by flow cytometry (FACS Calibur, BD).
Library Generation
Positions I121, A123, F125, and E129 of the IDCL region were
fully randomized by two fragments overlapping PCR using
plasmid pCTCON-PCNA as template. The two PCNA gene
fragments were amplified using two sets of primers (fr-Lib1 and
rev-NNS; rev-Lib1 and fr-NNS, Table S3), assembled, and further
amplified using nested primers. A naı ¨ve library was generated by
in vivo recombination to obtain ,1610
6 colonies oversampling
the PCNA library diversity.
Library Selection
The naı ¨ve library was induced and labeled with different PIP
peptides, as described above. EBY100 cells (1610
7) displaying the
PCNA library were labeled, analyzed, and sorted using a FACS
(Vantage, BD). Three to five iterative rounds of enrichment were
performed. In each round, multiple ‘‘positive’’ events (3–5610
4),
corresponding to cells found within the top 1%–2% of the green
and red fluorescence intensity area, were collected into growth
media and plated on agar plates for a new round of enrichment.
For initial sorting of the naı ¨ve library, a sort gate of the top 5% of
fluorescent cells was used. To increase the stringency of selection, a
decreased peptide concentration was used in each subsequent
round. Selection rounds were continued until no further
enrichment was obtained.
Cloning and Bacterial Expression of PCNA Mutants from
FACS-Enriched Libraries
A pool of plasmids from the last round of FACS enrichment was
PCR-amplified using the primers fr-pET/PCNA and rev-pET/
PCNA (Table S3) and cloned into plasmid pET28. Single E. coli
BL21cells,transformed withthe resultingplasmids, were inoculated
into 10 ml LB media containing 50 mg/ml kanamycin, grown to
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at 30uC. The cells were then harvested, lysed in PBS supplemented
with 0.1% Triton and 200 mg/ml lysozyme, centrifuged, and the
cleared supernatant was collected. Total protein concentration of
the different mutants was determined using a BCA protein assay kit
(Thermo Scientific) and analyzed by SDS-PAGE to verify the
similarity of PCNA expression levels.
ELISA Screening of PCNA Mutants
ELISA plates (Griener Microlon 96W) were coated with
0.2 mg/ml streptavidin (Pierce) and 0.1 mg/ml of biotinylated
PIP peptides, as described [44]. Following peptide coating, the
plates were incubated with the cleared lysate generated above at
appropriate dilutions and shaken at 25uC for 1 h. Plates were then
washed with PBS supplemented with 0.05% Tween-80 (PBST)
and each well was incubated with mouse a-66His-tag antibodies
(Santa-Cruz Biotechnology) diluted by a factor of 1:2000 and then
with secondary HRP-conjugated goat a-mouse antibodies (Jack-
son, 1:5000). The HRP chromogenic TMB substrate solution
(Dako) was added and the reaction was stopped by the addition of
100 mL of 1 M sulfuric acid and recorded at 450 nm using a
Tecan Infinite M200 plate reader.
Large-Scale Expression and Purification of WT and
Mutant PCNA
E. coli BL21 cells were induced and lysed as above in a volume
of 0.5 L with minor modifications. Briefly, following centrifugation
the cell pellet was sonicated in 20 ml of lysis buffer, centrifuged,
and the cleared supernatant was loaded on a pre-equilibrated
column containing 2 mL Ni-NTA resin (Qiagen). The columns
containing the lysates were gently shaken by inversion for 30 min
at 25uC. The resin was then washed with 30 ml of wash buffer and
PCNA was eluted in 1 ml fractions upon addition of elution buffer.
Fractions containing PCNA were pooled and dialyzed against
storage buffer. Protein concentration was determined with a BCA
protein assay kit (Pierce) and analyzed by SDS-PAGE. The
protein solutions were stored in 1 ml aliquots of 2 mg/ml at
220uC. Lysis, wash, elution, and storage buffers were derived
from the activity buffer based on 300 mM NaCl, 50 mM Tris-
HCl, pH 8, and supplemented with imidazole, according to the
manufacturer’s recommendations.
Gel Filtration and CD Analysis of PCNA
WT and mutant PCNA were purified as described above. Gel
filtration chromatography was performed on a Superdex 200 10/
300 GL column (GE Healthcare) using the A ¨KTApurifier FPLC
system. All proteins were run in activity buffer at monomer
concentrations of 3–8 mM at which WT PCNA is a trimer and
Pol30-52 is a monomer [34]. CD spectra were obtained for WT
PCNA and six representative mutants using the Jasco J-810 CD
Spectropolarimeter. All measurements were performed at room
temperature in activity buffer. Data were obtained for the
wavelength range of 204–260 nm and normalized to protein
concentration to obtain molar ellipticity.
SPR Analysis of Selected Mutants
Protein interaction assays were carried out using the ProteOn
XPR36 (Bio-Rad) instrument. WT or PCNA mutants (0.4 to
5.2 fmol) were immobilized on the surface of a GLM sensor chip
by a carbodiimide-activated succinimide-coupling method, as
specified by the manufacturer. All SPR experiments were
performed by flowing 150 ml of the target peptide at a flow rate
of 30 ml/min onto the PCNA-bound chip. Different concentra-
tions (5–5,000 nM) of PIP peptides (Table 1) were injected over
the PCNA chip, and binding parameters were determined using
ProteOn XPR36 software (Bio-Rad). The ligand (PCNA) and
analyte (peptide) buffers were PBST and 150 mM NaCl, 1 mM
EDTA, 0.01% Tween-80, 30 mM Hepes, pH 7.5, respectively.
Y2H Analysis
Y2H analysis was performed using the Yeast Two Hybrid
Phagemid vector kit (Stratagene), following the manufacturer’s
instructions. The pAD-PCNA-WT/mutant plasmids were used as
bait while plasmids encoding 12 different PCNA partners (Table 1
and Table S1) were used as prey. The YRG2 host strain (Stratagene)
was cotransformed with pAD-PCNA WT/mutant and pBD-partner
plasmids in all possible combinations using the LiAC method. Single
transformants were grown in liquid SC-Leu-Trp to O.D600 10,
washed twice with DDW, and diluted to an initial OD600 of 0.3. A
series of 10-fold serial dilutions was then spotted onto selective SC-
Leu-Trp-His plates and incubated at 30uC for 3 d. For quantitative
Y2H, the generation time of the indicated mutants and their
respective partners were calculated from their growth curves in
liquid SC-Leu-Trp-His media. Cells were grown overnight in SC-
Leu-Trp, washed twice with ddH2O, and diluted by a factor of 1:50
into 10 ml of pre-warmed SC-Leu-Trp-His. O.D600 measurements
of the cultures were taken at the indicated time; the generation time
(t) was calculated from the growth curves according to the equation
ODt=OD 062
t/t. The generation time calculated for each culture is
an average of at least 3 independent experiments.
In Vivo Characterization of Novel Mutants Serving as the
Sole PCNA Source
Novel haploids containing PCNA mutants were generated using
the plasmid shuffling method. Briefly, a pol30::KanMX magic
marker heterozygote diploid strain BY4743 (Open Biosystem) was
transformed with plasmid pRS316-POL30. Following dissection of
the diploid, a haploid containing the CAN+ gene and plasmid
pRS316-POL30 as a sole source of PCNA was generated. This
host strain was transformed with selected pRS315-pol30 mutants,
plated on SC-Ura-Leu plates, followed by replica plating to SC-
Leu+5FOA plates. Haploids, containing PCNA mutants as a sole
source, were further verified by plating on either SC-Leu or SC-
Ura plates. For testing selected PCNA mutants, a haploid
containing rad27::HYG, rad30::HYG, pol32::HYG, msh6::HYG,
or ung1::HYG were generated using plasmid pAG32 by
conventional genetic approaches. Growth of the PCNA mutant
strains in the presence of 120 mM HU (Toronto Research
Chemicals) or 0.02% MMS (Sigma) was performed as described
[45]. To examine the effects of partner overexpression on pol30
mutant strains, these strains were transformed with various
plasmids containing GST-tagged PCNA partner encoding genes
under the control of a GAL1/10 inducible promoter, as previously
described [46]. Overnight cultures were plated in serial dilutions
on SC-Ura containing either glucose or galactose with or without
DNA-damaging agents, as described above.
Analysis of Spontaneous Mutation Rates and Mutation
Spectra at the CAN1 Gene
The mutation rates for the different pol30 mutant strains
described in this study were determined by fluctuation test analysis
using the Lea and Coulson method [47,48]. The different strains
were plated as single colonies on SC-Leu plates and allowed to
grow for 3 d at 30uC. At least 25 single colonies from each strain
were excised from the plate and resuspended in 1 ml of sterile
water to an O.D600 of 0.7. Appropriate dilutions of the cells were
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to obtain the number of viable cells (Nt) and the number of
canavanine-resistant cells (r), respectively. Using the Lea and
Coulson method [47], the number of mutations (m) per colony was
derived from the number of canavanine resistant-colonies (r)
across parallel cultures, using the following equation: m/r-
ln(m)21.24=0. The m values were then used to calculate the
mutation rate, M, using the following equation: M=m/Nt, where
Nt is the average number of viable cells per plating. The different
M values were sorted to obtain the median. The low and high
values for the 95% confidence interval for each rate were obtained
using the confidence interval median test. The m, M, and 95%
confidence interval values were determined using the Fluctuation
Analysis CalculatOR (FALCOR) program, with r and Nt as the
input values (http://www.keshavsingh.org/protocols/FALCOR.
html) [49]. The significance of differences between the mutation
rates of the mutants and the WT was estimated by the Wilcoxon-
Mann-Whitney test to obtain p values. To analyze the mutation
spectra of pol30 mutant strains, genomic DNA was extracted from
individual CAN1-resistant colonies. The CAN1 locus was PCR
amplified using upstream and downstream primers and the PCR
product was sequenced using 3 primers spanning the entire ORF.
Analysis of sequences was performed using the Geneious program.
ELISA for Detecting PCNA-Partner Complexes Extracted
from Yeast Cells
Yeast cell extracts were generated from 0.5 L of logarithmic
cultures using conventional methods. Briefly, cell pellets were lysed
with Cell Lytic (Sigma), supplemented with protease inhibitors
(Sigma) and glass beads, as suggested by the manufacturer.
Following centrifugation, cell extracts were collected and protein
concentration was determined by the BCA method. ELISA plates
coated with rabbit a-PCNA antibodies (1:3000, Adar Biotech) were
incubated with 100 ml ofyeast cell extract ata proteinconcentration
of 3 mg/ml for 1 h at RT. Following 3 washing steps with PBST,
wells were incubated with either mouse a-His antibodies (1:500,
Santa Cruz Biotechnology), to detect PCNA adsorption, or a-GFP
antibodies (1:500, Roche), to detect the presence of GFP-tagged
PCNA partners bound to PCNA (see Figure 4). Plates were then
washed 3 times with PBST and incubated with secondary HRP-
conjugated goat a-mouse antibodies (1:2000, Jackson). PCNA-
partner complex levels were calculatedas theratio of theGFPsignal
to the PCNA signal detected for the same cell extract. Values
represent averages of at least 5 independent repeats.
Western Blot Analysis of Crude Yeast Extracts
Selected haploid PCNA mutants were grown to OD600 0.8,
centrifuged, and lyzed using cell lytic solution (Sigma) supple-
mented with protease inhibitor cocktail (Sigma), following the
manufacturer’s instructions. Following TCA treatment, samples
containing 10 mg of crude lysates were loaded on a 10% SDS-
PAGE gel and subjected to western blot analysis using rabbit a-
PCNA (custom-made by Adar Biotech, 1:2000 in PBS+1% BSA)
and mouse a-Pgk1 (Invitrogen, 1:7000 in PBS+1% BSA)
antibodies. Antibody binding was detected using either HRP-
conjugated goat a-rabbit (1:10,000) or HRP-conjugated goat a-
mouse (1:10,000) antibodies, respectively. The latter were used to
detect the yeast Pgk1 protein that served as a loading control.
Supporting Information
Figure S1 PIP peptide sequences derived from the
different target partners (see text for detailed explana-
tion). Conserved residues are highlighted.
Found at: doi:10.1371/journal.pbio.1000507.s001 (0.50 MB TIF)
Figure S2 Sequence alignment of the IDCL region of
PCNA from different organisms. The four non-conserved
residues that were completely diversified in the mutant library are
highlighted with a red arrow. The PCNA SUMOylation site was
not mutated and is highlighted with a blue arrow.
Found at: doi:10.1371/journal.pbio.1000507.s002 (0.85 MB TIF)
Figure S3 Yeast surface display of PCNA. (A) PCNA is
displayed as an Aga2 (grey) fusion on the yeast cell
surface. Expression is detected through fluorescent antibody
binding to the c-Myc epitope tag (light blue) while binding of the
biotinylated PIP peptide (orange) is detected using fluorescently-
labeled streptavidin (green). (B–D) Flow cytometry dot plots of
yeast cells displaying WT PCNA (B–C) and the inactive PCNA79
mutant (D) incubated with fluorescein isothiocyanate (FITC)-
labeled antibodies to the c-Myc epitope (x-axis) to analyze PCNA
display levels. The specificity of PCNA binding for PIP peptides
was detected following incubation with biotinylated PIP peptide
derived from Rad30 (B and D) and mutated Rad30 in which the
two conserved phenylalanine residues of the PIP peptide are
mutated to alanine (C), followed by incubation with allophyco-
cyanin (APC)-labeled streptavidin (y-axis).
Found at: doi:10.1371/journal.pbio.1000507.s003 (0.06 MB PDF)
Figure S4 Yeast two hybrid analysis of selected PCNA-
partner interactions. The WT and mutant PCNA were fused
to the DNA-activating domain (pAD) and the Rad30 (A), Rad27
(B), Pol32 (C), MSH6 (D), and UNG1 (E) partners were fused to
the DNA-binding domain (pBD). The transformed YRG2 yeast
strains were grown on liquid selective media lacking leucine (L),
tryptophan (W), and histidine (H, right) to detect for PCNA-
partner interactions.
Found at: doi:10.1371/journal.pbio.1000507.s004 (0.15 MB TIF)
Figure S5 Yeast two hybrid analysis of selected PCNA-
partner interactions. The WT and mutant PCNA were fused
to the DNA-activating domain (pAD) and the Rad30 (A), Rad27
(B), Pol32 (C), MSH6 (D), and UNG1 (E) partners were fused to
the DNA-binding domain (pBD). The transformed YRG2 yeast
strains were serial diluted and spotted on selective plates lacking
leucine (L) and tryptophan (W, left) and then spotted on selective
plates further lacking histidine (H, right) to detect for PCNA-
partner interactions.
Found at: doi:10.1371/journal.pbio.1000507.s005 (0.30 MB TIF)
Figure S6 Analysis of PCNA trimers and secondary
structure contents of six PCNA mutants and WT PCNA.
(A) Gel filtration chromatography analysis of WT PCNA (Pol30p)
and the six PCNA mutants indicate no significant alterations in
trimer formation. The previously identified PCNA mutant
defective in trimerization (Pol30-52, [34]) elutes as a peak at
,16 ml, corresponding to the monomeric form of PCNA. The
retention volumes and molecular masses (,90 kDa for the trimer
and 30 kDa for the monomer) were calibrated using standard
molecular markers. (B) Circular dichroism analysis of PCNA WT
and mutants, indicating similar secondary structure contents.
Found at: doi:10.1371/journal.pbio.1000507.s006 (0.65 MB
TIF)
Figure S7 Western blot analysis of the expression level
of WT and selected PCNA mutants in yeast (upper
panel): 1-pol30-Rad27E6, 2-pol30-Rad30E2, 3-WT PCNA,
4-pol30-79, 5-pol30-Pol32E5, 6-pol30-Ung1E2, 7-pol30-
Msh6E2 (see Table 1 in the main text for sequence and
characterization of the mutants) using anti-PCNA anti-
The Fragility of PCNA Mediated DNA Replication
PLoS Biology | www.plosbiology.org 13 October 2010 | Volume 8 | Issue 10 | e1000507bodies. The expression of Pgk1 was monitored as a loading
control using anti-Pgk1 antibodies (bottom panel).
Found at: doi:10.1371/journal.pbio.1000507.s007 (0.03 MB PDF)
Figure S8 WT and pol30 mutant sensitivity examined on
the background of the parent (left) or rad27-deleted
(right) strains. The rad27 deletion results in suppression of the
growth sensitivity in the case of the pol30-Rad30E2 or pol30-
Ung1E2 strains. In contrast, the rad27 deletion had only weak
effect on the growth sensitivity of the pol30-Rad27E6 or pol30-
Msh6E2 mutant strains.
Found at: doi:10.1371/journal.pbio.1000507.s008 (0.28 MB
DOC)
Figure S9 The effects of overexpression of Rad27,
Rad30, Pol32, and Msh6 on the growth sensitivity of
the POL30, pol30-79, pol30-Rad27E6, or pol30-Pol32E5
strain. Overexpression of the different partners did not reduce
the growth sensitivity of the strains to DNA damaging agents.
Found at: doi:10.1371/journal.pbio.1000507.s009 (0.43 MB TIF)
Table S1 Yeast two hybrid analysis of binding of
selected PCNA mutants with seven additional partners
not described in Table 1 of the main text.
Found at: doi:10.1371/journal.pbio.1000507.s010 (0.01 MB
DOC)
Table S2 CAN1 mutation spectra for POL30 mutants.
Found at: doi:10.1371/journal.pbio.1000507.s011 (0.08 MB
DOC)
Table S3 Sequences of oligonucleotides used in this
study.
Found at: doi:10.1371/journal.pbio.1000507.s012 (0.05 MB
DOC)
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